Gynecologic Oncology

Gynecologic Oncology

Comprehensive Gynecologic Cancer Care — Advanced Surgery, Precision Medicine, Personalized Support.

Robotic and fertility-sparing surgery, targeted systemic therapy, and survivorship programs for cancers of the ovary, uterus, cervix, vulva, and vagina.

The Gynecologic Oncology Service offers comprehensive cancer care that includes high-ADR screening colonoscopy, advanced endoscopic resection (EMR/ESD), EUS & ERCP staging, cutting-edge imaging (PET-CT, MRI liver protocols), molecular profiling, minimally invasive and robotic surgery, organ-preservation protocols, liver-directed therapies (TACE, Y-90), and state-of-the-art systemic and radiation therapies. Our weekly Gyne-Onc Tumor Board ensures every patient receives a personalized, guideline-based treatment plan.

1,150+
gynecologic cancer cases treated in 2024
78%
of resections for early-stage disease performed using minimally invasive or robotic techniques
<7
days from biopsy to multidisciplinary treatment plan
23
active Phase I–III clinical trials, including PARP inhibitors, ADC, and immunotherapy

Common Conditions & Subspecialty Clinics.

  • Epithelial ovarian cancer 
  • Germ-cell tumors
  • Sex-cord stromal tumors 
  • Secondary cytoreductive surgery 
  • Hyperthermic intraperitoneal chemotherapy (HIPEC) 
  • Endometrial carcinoma 
  • Uterine sarcoma 
  • Cervical squamous-cell carcinoma and adenocarcinoma 
  • Fertility-sparing trachelectomy 
  • Vulvar squamous-cell carcinoma 
  • Paget disease of the vulva 
  • Bartholin-gland carcinoma 
  • Vaginal cancer 
  • Complete and partial hydatidiform mole 
  • Choriocarcinoma 
  • Placental-site trophoblastic tumor 
  • hCG surveillance and chemotherapy 
  • Oocyte and embryo cryopreservation 
  • Ovarian tissue freezing 
  • Ovarian transposition prior to pelvic radiation or surgery 
  • BRCA1/2, Lynch syndrome, RAD51C/D mutation carriers 
  • Risk-reducing surgery (e.g., salpingo-oophorectomy, hysterectomy) 
  • Surveillance and chemoprevention 

Procedures & Treatments.

  • Pelvic Exenteration & Complex Reconstruction with plastic surgery support

  • Fertility-Sparing Surgery – Radical trachelectomy, unilateral oophorectomy, cystectomy

  • HIPEC (intraperitoneal heated chemotherapy) during interval debulking

  • Sentinel-Node Mapping using ICG and near-infrared imaging

  • Robotic or Laparoscopic Cytoreductive Surgery with fluorescence perfusion

  • Robotic Radical Hysterectomy & Lymphadenectomy (da Vinci Xi)

  • Hormonal Therapy – Progestins, aromatase inhibitors for low-grade endometrioid carcinoma

  • Immunotherapy – PD-1 inhibitors for MSI-H/dMMR endometrial & PD-L1+ cervical cancers

  • Antibody-Drug Conjugates (mirvetuximab, tisotumab) for recurrent disease

  • PARP Inhibitors (olaparib, niraparib) maintenance for BRCA & HRD tumors

  • Platinum/Taxane Chemotherapy with dose-dense and intraperitoneal options

  • SBRT boost for oligometastatic lesions

  • Image-Guided Adaptive Brachytherapy (3-D MRI-based) for cervix & vault

  • IMRT / VMAT pelvic radiation with bowel-sparing techniques

  • Genetic counseling & cascade testing for hereditary syndromes

  • Lymphedema prevention & management clinic

  • Sexual health and pelvic-floor rehabilitation

  • Onco-fertility counseling and ovarian suppression

Care Pathway & Coordination.

1
Rapid Referral & Diagnostics

Rapid Referral & Diagnostics

Pelvic MRI, PET-CT, tumor markers, biopsy within 5 days.

2


GI Tumor Board

GI Tumor Board

Consensus plan (surgery, neoadjuvant, systemic, trials).

3


Treatment Phase

Treatment Phase

Timely start of therapy; nurse navigator coordinates appointments.

4


Response Assessment

Response Assessment

Imaging labs per protocol; ctDNA monitoring.

5


Surgery / Intervention

Surgery / Intervention

Minimally invasive resection or liver-directed therapy.

6


Survivorship Follow-up

Survivorship Follow-up

Surveillance schedule, wellness programs, rapid re-entry for recurrence.

Technology & Facilities.

  • da Vinci Xi Robotic Suites with Firefly ICG Imaging

  • Hybrid OR & Intra-operative CT for complex resections

  • 3-T Pelvic MRI & 64-slice PET-CT for precise staging

  • MRI-Guided Brachytherapy Suite

    Real-time applicator placement

  • On-site Genomics Lab

    HRD, MSI, and comprehensive NGS panels

  • Fertility Preservation Lab

    Oocyte/embryo cryostorage, ovarian tissue cryobank

Patient Stories.

Click Here
A Healing Journey At Burjeel Cancer Institute

A Healing Journey At Burjeel Cancer Institute

Bassam

Multiple Myeloma

Click Here
Welcoming Our Little Warrior

Welcoming Our Little Warrior

Maryam Violeta

Spina Bifida Surgery In The Womb

Frequently Asked Questions.

Will minimally invasive surgery affect survival?

For early-stage disease, laparoscopic/robotic outcomes match open surgery with faster recovery. Advanced cases are assessed individually.

Can I keep my fertility?

Fertility-sparing options are available for certain cervical and ovarian tumors—our onco-fertility team will discuss suitability.

What genetic tests do I need?

BRCA1/2, Lynch (MMR genes), and others based on family history and tumor profile—covered by our genetics clinic.

Is HIPEC safe?

Performed by experienced surgeons; evidence shows improved survival in select ovarian cancer cases with acceptable toxicity.

Ready to Start Your Health Journey?

Take the first step towards better health with our expert team.

Book Appointment Contact Us

Call Now Appointment